Literature DB >> 26617959

LpxC Inhibitors as Effective Therapy Against Multidrug Resistant Bacterial Infections.

Ahmed F Abdel-Magid1.   

Abstract

Year:  2015        PMID： 26617959      PMCID： PMC4645236          DOI： 10.1021/acsmedchemlett.5b00391

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) inhibitors: a new class of antibacterial agents.

Authors:  J Zhang; L Zhang; X Li; W Xu
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 2.  New antibacterial agents: patent applications published in 2011.

Authors:  Thomas A Keating; Troy Lister; Jeroen C Verheijen
Journal:  Pharm Pat Anal       Date:  2014-01

Review 3.  Mechanism and inhibition of LpxC: an essential zinc-dependent deacetylase of bacterial lipid A synthesis.

Authors:  Adam W Barb; Pei Zhou
Journal:  Curr Pharm Biotechnol       Date:  2008-02       Impact factor: 2.837
  3 in total
  1 in total

1.  3D-QSAR, Molecular Docking and Molecular Dynamics Simulation of Pseudomonas aeruginosa LpxC Inhibitors.

Authors:  Ke Zuo; Li Liang; Wenyi Du; Xin Sun; Wei Liu; Xiaojun Gou; Hua Wan; Jianping Hu
Journal:  Int J Mol Sci       Date:  2017-05-06       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.